Asia Pacific Apheresis Market Size (2024 - 2029)

The Asia Pacific apheresis market is projected to experience significant growth over the forecast period, driven by an increasing disease burden, heightened demand for blood components, and advancements in apheresis technology. Despite the high capital investment and costs associated with apheresis procedures posing challenges, the market is expected to expand due to the rising prevalence of complex immune disorders, technological innovations, and supportive government initiatives. The market's expansion is further supported by increased awareness and participation in blood donation campaigns, although the technical and medical demands of apheresis technology remain a consideration.

Home Market Analysis Healthcare Research Medical Devices Research Treatment Equipment Research Apheresis Research Asia Pacific Apheresis Industry Market Size

Market Size of Asia Pacific Apheresis Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Asia Pacific Apheresis Market_1
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 0.74 Billion
Market Size (2029) USD 1.22 Billion
CAGR (2024 - 2029) 10.57 %

Major Players

Asia Pacific Apheresis Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Asia Pacific Apheresis Market Analysis

The Asia Pacific Apheresis Market size is estimated at USD 0.74 billion in 2024, and is expected to reach USD 1.22 billion by 2029, growing at a CAGR of 10.57% during the forecast period (2024-2029).

The major factors attributing to the growth of the Asia Pacific apheresis market are increasing diseases burden, rise in demand for blood components and associated safety and technological advancement in the development of new apheresis techniques. However, the factors such as high capital investment and cost associated with apheresis procedures is expected to restrain the market.

Apheresis has now become a popular mode of treatment for multiple complex immune disorders and there has been a remarkable change in the scenario pertaining to therapeutic apheresis in Asia-Pacific. With the increasing number of diseases and accident cases, along with technological advancements, the market studied is expected to experience a boost during the forecast period. Additionally, the rising number of government initiatives, blood donation camps, and increasing awareness about healthcare are the factors responsible for the growth of the market studied. Apheresis technology is expensive. It is also technically and medically demanding.

Asia Pacific Apheresis Industry Segmentation

Apheresis is a medical technique, where the blood of an individual, either a donor or patient, is passed through an apparatus that separates a particular constituent and returns the rest of the blood to the circulatory system. This is an extracorporeal therapy.

By Product
Devices
Disposables
By Indication
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Other Indications
By Procedure
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Other Procedures
Geography
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Need A Different Region Or Segment?
Customize Now

Asia Pacific Apheresis Market Size Summary

The Asia Pacific apheresis market is poised for significant growth, driven by an increasing disease burden and a rising demand for blood components. Technological advancements in apheresis techniques are further propelling market expansion. Apheresis has emerged as a crucial treatment for complex immune disorders, with its application in therapeutic apheresis witnessing notable progress in the region. The market's growth is supported by government initiatives, blood donation camps, and heightened healthcare awareness. However, the high capital investment and costs associated with apheresis procedures pose challenges to market growth. The prevalence of neurological diseases, similar to those in Western countries, and the specific disease features in Asia, such as a high proportion of strokes among the youth and a high prevalence of certain neurological disorders, also influence the market dynamics.

The Asia Pacific apheresis market is moderately competitive, with a few major players currently dominating the market share. Companies like Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Kaneka Corporation, and Terumo Corporation are key players in this space. As the prevalence of diseases continues to rise in the region, the use of apheresis is expected to increase, potentially attracting new entrants to the market. Plasma exchange, a well-established therapeutic procedure, plays a significant role in treating neurological autoimmune disorders by eliminating inflammatory mediators. This therapeutic approach is beneficial for various neurological diseases, contributing to the market's growth trajectory.

Explore More

Asia Pacific Apheresis Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Disease Burden in Asia

      2. 1.2.2 Rise in Demand for Blood Components and Associated Safety

      3. 1.2.3 Technological Advancement in the Development of New Apheresis Techniques

    3. 1.3 Market Restraints

      1. 1.3.1 High Capital Investment and Cost Associated with Apheresis Procedures

      2. 1.3.2 Risk of Blood Contamination

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Devices

      2. 2.1.2 Disposables

    2. 2.2 By Indication

      1. 2.2.1 Renal Disorders

      2. 2.2.2 Hematological Disorders

      3. 2.2.3 Neurological Disorders

      4. 2.2.4 Autoimmune Disorders

      5. 2.2.5 Other Indications

    3. 2.3 By Procedure

      1. 2.3.1 Plasmapheresis

      2. 2.3.2 Plateletpheresis

      3. 2.3.3 Erythrocytapheresis

      4. 2.3.4 Leukapheresis

      5. 2.3.5 Other Procedures

    4. 2.4 Geography

      1. 2.4.1 China

      2. 2.4.2 Japan

      3. 2.4.3 India

      4. 2.4.4 Australia

      5. 2.4.5 South Korea

      6. 2.4.6 Rest of Asia Pacific

Asia Pacific Apheresis Market Size FAQs

The Asia Pacific Apheresis Market size is expected to reach USD 0.74 billion in 2024 and grow at a CAGR of 10.57% to reach USD 1.22 billion by 2029.

In 2024, the Asia Pacific Apheresis Market size is expected to reach USD 0.74 billion.

APAC Apheresis Market Report Snapshots

APAC Apheresis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)